Dr Stephen Nutt is a recipient of the Leukemia & Lymphoma Society – Snowdome Foundation – Leukaemia Foundation Translational Research Project Grant. He is an immunologist that has looked at cell survival and turned it on its head to see how he can then kill cells. His research is fascinating and hopefully it will result … Continued
Dr Ashwin Unnikrishnan is one of the recipients of the “Leukemia & Lymphoma Society-Snowdome Foundation-Leukaemia Foundation (LLS-SF-LF) Translational Research Project” Grants. His project is in the area of myelodysplastic syndrome (MDS). He kindly took time out of his busy schedule to answer some questions. Q.You have a special interest in MDS – how did this … Continued
The Snowdome Foundation has joined forces with the Leukaemia Foundation and America’s The Leukemia & Lymphoma Society (LLS) to fund blood cancer research projects with Australian researchers through the LLS Translational Research Program (TRP). The TRP is an LLS initiative that aims to fund new and innovative research that shows high promise for translating basic biomedical knowledge to … Continued
The plight of one of Australia’s favourite actors to multiple myeloma captured the attention of many but in particular his close school friends. Tom Long was a student at Geelong Grammar, famous for its Timber Top year that seems to build a friendship bond that lasts well beyond the school years. When his school year … Continued
Another incredible story of CAR T-cell therapy saving an Australian blood cancer patient’s life. However, the young mum had to travel to the USA for treatment. To hear her story click here. Snowdome is raising funds to bring CAR T-cell therapy to Australia so people like Gina and Tom and many others, we have heard … Continued
The Federal Government announced that it will fund Chimeric Antigen Receptor T cell (CAR T-cell) therapy with Kymriah for the treatment of acute lymphoblastic leukaemia (ALL) in paediatric and young adult patients who have relapsed or do not respond to initial treatment. This is fabulous news with ALL affecting approximately 30 patients every year. We … Continued
As of 1st May 2019 Inotuzumab (Besponsa) will be available on the PBS for patients with relapsed acute lymphocytic leukaemia (ALL) or refractory CD22 positive B-cell precursor ALL. The treatment costs $120,000 per course but due to funding you will only pay $40.30 or $6.50 (for concession card holders) a course. Acute lymphocytic leukaemia occurs … Continued
Chimeric Antigen Receptor T-cell (CAR T-cell) therapies are providing Australian blood cancer patients with real hope. From the Federal Government announcing an investment in the Peter MacCallum Cancer Centre to support CAR T-cell treatment to the incredibly heart-breaking news of a much loved Aussie Actor, Tom Long having to fly to the USA for CAR … Continued
The FireFlies Antipodes suffered on their bikes for 800kms in order to raise funds for blood cancer research. Snowdome co-Founder Grant Rutherford joined the FireFlies, here is his story. For those who suffered, I drove. The Fireflies Antipodes ride from Christchurch to Queenstown in New Zealand is done. It was done and dusted days ago … Continued